These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 8129036)

  • 1. p53 alteration in gastric precancerous lesions.
    Shiao YH; Rugge M; Correa P; Lehmann HP; Scheer WD
    Am J Pathol; 1994 Mar; 144(3):511-7. PubMed ID: 8129036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p53 mutations in the non-neoplastic mucosa of the human stomach showing intestinal metaplasia.
    Ochiai A; Yamauchi Y; Hirohashi S
    Int J Cancer; 1996 Feb; 69(1):28-33. PubMed ID: 8600055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Numerical aberration and point mutation of p53 gene in human gastric intestinal metaplasia and well-differentiated adenocarcinoma: analysis by fluorescence in situ hybridization (FISH) and PCR-SSCP.
    Gomyo Y; Osaki M; Kaibara N; Ito H
    Int J Cancer; 1996 May; 66(5):594-9. PubMed ID: 8647618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p53 gene mutations and protein nuclear accumulation are early events in intestinal type gastric cancer but late events in diffuse type.
    Ranzani GN; Luinetti O; Padovan LS; Calistri D; Renault B; Burrel M; Amadori D; Fiocca R; Solcia E
    Cancer Epidemiol Biomarkers Prev; 1995; 4(3):223-31. PubMed ID: 7606196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of p53 expression in precancerous and malignant gastric mucosa.
    Romiti A; Moretti A; Vecchione A; Muraro R; Feudi ML; Rinaldi V; Mancini R; Valli C; Mozzicafreddo A; Frati L; Tomao S
    Oncol Rep; 1998; 5(1):109-13. PubMed ID: 9458303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The RR genotype of codon 72 of p53 gene reduces the development of intestinal metaplasia.
    Szoke D; Molnár B; Solymosi N; Sipos F; Galamb O; Gyorffy A; Tulassay Z
    Dig Liver Dis; 2009 Mar; 41(3):179-84. PubMed ID: 18567547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of E-cadherin expression in gastric intestinal metaplasia and later stage p53 altered expression in gastric carcinogenesis.
    Mingchao ; Devereux TR; Stockton P; Sun K; Sills RC; Clayton N; Portier M; Flake G
    Exp Toxicol Pathol; 2001 Sep; 53(4):237-46. PubMed ID: 11665847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Point mutation of TP53 suppressor gene in pre-neoplastic and neoplastic lesions of the stomach].
    Araya JC; Roa JC; Villaseca MA; Roa I; Guzmán P; Alvarado C; Melo A
    Rev Med Chil; 2003 Apr; 131(4):359-65. PubMed ID: 12870229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p53 mutations and microsatellite instabilities in the subtype of intestinal metaplasia of the stomach.
    Kim SS; Bhang CS; Min KO; Chae HS; Choi SW; Lee CD; Lim KW; Chung IS; Park DH
    J Korean Med Sci; 2002 Aug; 17(4):490-6. PubMed ID: 12172044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p53 gene alteration in atypical epithelial lesions and carcinoma in patients with idiopathic pulmonary fibrosis.
    Kawasaki H; Ogura T; Yokose T; Nagai K; Nishiwaki Y; Esumi H
    Hum Pathol; 2001 Oct; 32(10):1043-9. PubMed ID: 11679937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutations of the K-ras and p53 genes in gastric adenocarcinomas from a high-incidence region around Florence, Italy.
    Hongyo T; Buzard GS; Palli D; Weghorst CM; Amorosi A; Galli M; Caporaso NE; Fraumeni JF; Rice JM
    Cancer Res; 1995 Jun; 55(12):2665-72. PubMed ID: 7780983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Multiple gene alterations involved in the processor of human gastric carcinogenesis].
    Lu Y; Li Z; Sun M
    Zhonghua Yi Xue Za Zhi; 1995 Nov; 75(11):679-82, 710-1. PubMed ID: 8697090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In situ analysis of tissue dynamics and p53 expression in human gastric mucosa.
    Imatani A; Sasano H; Yabuki N; Kato K; Ohara S; Asaki S; Toyota T; Nagura H
    J Pathol; 1996 May; 179(1):39-42. PubMed ID: 8691342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of p53 abnormalities in endoscopic gastric biopsies.
    Imatani A; Sasano H; Asaki S; Toyota T; Saito M; Masuda T; Nagura H
    Anticancer Res; 1996; 16(4A):2049-56. PubMed ID: 8712741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence that gastric pit dysplasia-like atypia is a neoplastic precursor lesion.
    Agoston AT; Odze RD
    Hum Pathol; 2014 Mar; 45(3):446-55. PubMed ID: 24529328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Expression of syndecan-1 at different stages in the course of gastric carcinoma and its significance].
    Xi YX; Song X; Chen J; Chen HX; Peng TS; Lin HL; Chen MH
    Zhonghua Zhong Liu Za Zhi; 2007 Mar; 29(3):193-6. PubMed ID: 17649635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microsatellite instability in precancerous lesions and adenocarcinomas of the stomach.
    Semba S; Yokozaki H; Yamamoto S; Yasui W; Tahara E
    Cancer; 1996 Apr; 77(8 Suppl):1620-7. PubMed ID: 8608553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p53 gene mutation and protein accumulation during neoplastic progression in Barrett's esophagus.
    Bian YS; Osterheld MC; Bosman FT; Benhattar J; Fontolliet C
    Mod Pathol; 2001 May; 14(5):397-403. PubMed ID: 11353048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of intestinal metaplasia in stomach of dogs and expression of tumor-related proteins in animal gastric mucosa lesions.
    Wang D; Fang D; Liu W
    Chin Med J (Engl); 2000 Apr; 113(4):336-9. PubMed ID: 11775231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p53 tumor suppressor gene mutation in early esophageal precancerous lesions and carcinoma among high-risk populations in Henan, China.
    Gao H; Wang LD; Zhou Q; Hong JY; Huang TY; Yang CS
    Cancer Res; 1994 Aug; 54(16):4342-6. PubMed ID: 8044781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.